Hosted on MSN5mon
Merck’s Keytruda label expanded in the U.S. for mesotheliomaapproved a label expansion for its blockbuster therapy Keytruda to allow its use as a first-line combination therapy for mesothelioma, a cancer in the linings of internal organs. Accordingly ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback